| Mathematics and Statistics | Lifetime | 29 | GB 5 | 99.92 |
| Economics and Finance | Lifetime | 682 | GB 60 | 99.55 |
| Medical and Health Sciences | 2021-2025 | 946 | GB 90 | 99.78 |
| Statistics and Probability | Lifetime | 19 | GB 4 | 99.86 |
| Statistics, Probability and Uncertainty | Lifetime | 29 | GB 11 | 99.70 |
| Cardiology and Cardiovascular Medicine | Lifetime | 164 | GB 13 | 99.81 |
| Econometrics and Quantitative Economics | Lifetime | 368 | GB 28 | 99.61 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 392 | GB 49 | 98.82 |
| Health, Toxicology and Mutagenesis | Lifetime | 932 | GB 74 | 95.09 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 104 | GB 9 | 99.49 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 121 | GB 17 | 98.26 |
| Surgery | 2021-2025 | 832 | GB 58 | 92.65 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 9 | GB 2 | 99.95 |
| Statistical Methods in Clinical Trials | Lifetime | 3 | GB 2 | 99.92 |
| Meta-analysis and systematic reviews | Lifetime | 9 | GB 4 | 99.81 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 67 | GB 5 | 99.60 |
| Diabetes Treatment and Management | Lifetime | 97 | GB 14 | 99.54 |
| Heart Failure Treatment and Management | Lifetime | 92 | GB 5 | 99.64 |
| Advanced Causal Inference Techniques | Lifetime | 14 | GB 3 | 99.16 |
| Acute Myocardial Infarction Research | Lifetime | 122 | GB 7 | 99.59 |
| Cardiovascular Function and Risk Factors | Lifetime | 360 | GB 23 | 99.33 |
| Coronary Interventions and Diagnostics | Lifetime | 251 | GB 14 | 99.19 |
| Cardiac Imaging and Diagnostics | Lifetime | 778 | GB 49 | 98.83 |
| Blood Pressure and Hypertension Studies | Lifetime | 489 | GB 45 | 98.58 |
| Lipoproteins and Cardiovascular Health | Lifetime | 373 | GB 34 | 98.40 |
| Heavy Metal Exposure and Toxicity | Lifetime | 341 | GB 14 | 97.82 |
| Metabolism, Diabetes, and Cancer | Lifetime | 644 | GB 62 | 97.67 |
| Cardiac Health and Mental Health | Lifetime | 396 | GB 34 | 97.34 |
| Reliability and Agreement in Measurement | Lifetime | 23 | GB 6 | 96.71 |
| Statistical Methods and Bayesian Inference | Lifetime | 501 | GB 48 | 94.24 |
| Statistical Methods and Inference | Lifetime | 747 | GB 58 | 93.94 |
| Health and Medical Research Impacts | Lifetime | 717 | GB 79 | 89.15 |
| Optimal Experimental Design Methods | Lifetime | 415 | GB 38 | 92.10 |
| Heart rate and cardiovascular health | Lifetime | 215 | GB 21 | 87.29 |
| Delphi Technique in Research | Lifetime | 890 | GB 231 | 86.10 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 860 | GB 140 | 86.24 |
| Sodium Intake and Health | Lifetime | 989 | GB 65 | 87.61 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 75 | GB 14 | 98.86 |
| Heart Failure Treatment and Management | 2021-2025 | 66 | GB 7 | 99.32 |
| Diabetes Treatment and Management | 2021-2025 | 82 | GB 12 | 99.07 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 197 | GB 16 | 98.51 |
| Acute Myocardial Infarction Research | 2021-2025 | 124 | GB 21 | 97.93 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 79 | GB 8 | 97.61 |
| Statistical Methods in Clinical Trials | 2021-2025 | 72 | GB 15 | 93.35 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 415 | GB 35 | 93.99 |
| Pancreatic function and diabetes | 2021-2025 | 748 | GB 73 | 89.23 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 620 | GB 23 | 89.59 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 796 | GB 42 | 81.58 |
| Hormonal Regulation and Hypertension | 2021-2025 | 691 | GB 47 | 83.27 |
| Advanced Causal Inference Techniques | 2021-2025 | 236 | GB 24 | 82.61 |
| Sodium Intake and Health | 2021-2025 | 336 | GB 20 | 78.03 |
| Meta-analysis and systematic reviews | 2021-2025 | 683 | GB 120 | 75.15 |
| Potassium and Related Disorders | 2021-2025 | 863 | GB 51 | 56.10 |